MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from the private
placement
$231,675
Total cash provided by
financing activities
$231,675
Decrease in cash and cash
equivalents during the...
-$1,463,461
Canceled cashflow
$231,675
Operating cash flow used by
discontinued operations
$1,327,501
Accounts payable and
accrued liabilities
$113,837
Amortization of right-of-use
assets
$82,949
Amortization and
depreciation
$50,509
Prepaids and other
currents assets
-$42,225
Share-based compensation
$38,771
Unrealized foreign
exchange loss
-$24,480
Total cash used in
operating activities
-$1,695,136
Canceled cashflow
$1,680,272
Net loss
-$2,966,336
something is missing
-$294,638
Lease obligations
-$110,066
Other non-current
assets
$4,368
Back
Back
Cash Flow
source: myfinsight.com
InMed Pharmaceuticals Inc. (INM)
InMed Pharmaceuticals Inc. (INM)